Chris Elliott Fund Attends National LIVESTRONG and Genentech REV Forum to Turn Up the Dial on Cancer

Share Article

Conference Reaffirms CEF's Mission & Model: Providing immediate acces to advanced care and clinical trials for the best interest of the brain cancer patient.

The Chris Elliott Fund to End Brain Cancer

It was an honor to be one of 200 people nationwide to guide the direction of cancer care to where it will improve cancer survivorship and ultimately, save lives.

The Chris Elliott Fund's (CEF) Dellann Elliott was one of 200 cancer advocates, doctors and survivors invited to attend a day of collaboration and brainstorming for the future of cancer care &research. This conference was created by Genentech and LIVESTRONG--two leaders in the fight against cancer--and hosted in Austin, Texas on October 18th 2012. An outlet for organizations to collaborate and accelerate idea exchange and cancer solutions, the conference identified new and innovative ways to fight all types of cancers including the Chris Elliott Fund’s focus: brain cancer.

For the Chris Elliott Fund, this was a conference “that affirms the work we’re already pursuing as a brain cancer patient advocacy group focused on patient care,” said CEF Founder & President Dellann Elliott, “For me it was an honor to be one of 200 people nationwide to guide the direction of cancer care to where it will improve cancer survivorship and ultimately, save lives.”

The LIVESTRONG Foundation’s Vice President of Strategic Partnerships, Heidi Adams talks about the forum’s outcome, in an article in LIVESTRONG Quarterly (2012): “We want to catalyze action. Not just sit around and talk about something, but actually develop ideas and strategies to move the needle on this fight that we’re in every day.” Jen Mills, Ph.D., Senior Manager of Advocacy Relations at Genentech also speaks in the LIVESTRONG Quarterly article about the timeliness of moving the dial on cancer in new ways: “If you consider how patients should be treated, how we’re accessing medicine, how we’re developing drugs—it’s all constantly changing and we need to come together to discuss how to improve lives.”

A few goals that arose from the conference’s day of collaboration include:

  •     Opening accessibility for patients to clinical trials as the first line of treatment for cancers that do not have a cure
  •     A patient focused approach at the time of diagnosis, encouraging doctors to recommend more patients to clinical trials and assisting them in clinical trial enrollment
  •     Focusing on a need for electronic records to allow transparency and access for patients to necessary clinical trials.

These are goals that define CEFs mission and goals that CEF has been providing and will continue to provide to brain cancer patients.

The Chris Elliott Fund is an organization that provides free day-to-day patient and caregiver services to brain cancer patients and is an expert in the brain cancer field. Their mission, to provide immediate and timely access for patients to advanced care & clinical trials, is an issue that was a major focus point at the REV Forum conference. “CEF is already doing this, we are already moving the dial on cancer with the goal to get patients into clinical trials immediately upon diagnosis, to improve the day-to-day lives of cancer patients and their families and save & extends lives, “says CEF’s Elliott.

“We are excited to already have established this type of patient-oriented program and hope to be a model for other organizations in the United States looking to change current medical practices surrounding cancer treatment. We hope to to create an environment of not only more survivors of brain cancer but also, through our mission, encourage other organizations that aid cancer patients. We hope to encourage other organizations to put the patient first by making clinical trials the first line of treatment, that then feeds research that will ultimately cure these incurable diseases,” says Dellann Elliott.

If you have any questions regarding services CEF provides or questions about brain cancer patient care, CEF can be reached at 1.800.574.5703 or at info(at)chriselliottfund(dot)org.

About Brain Cancer:
Brain cancer is the most malignant form of cancer known to humankind with an average survival rate of two years. It is the second leading cause of cancer-related deaths in children under the age of 20. Each year, 8 of every 100,000 people in the U.S. are diagnosed with primary malignant brain tumors. Approximately 20,000 Americans die each year from this disease. Unlike some other cancers brain tumors do not discriminate against gender, ethnicity, age, overall fitness, or socioeconomic status. Over five hundred terminal cases of brain cancer will be diagnosed in the Seattle-Metro area alone this year.

About The Chris Elliott Fund/The Elliott Foundation:
The Chris Elliott Fund (CEF)/The Elliott Foundation (TEF) is a national 501(c)(3) non-profit organization with corporate offices in Seattle, WA whose goal is to End Brain Cancer. The Chris Elliott Fund's goal is to end brain cancer through patient advocacy, awareness, education and research. This is being done through immediate focus on improving outcomes of those diagnosed with brain tumors by providing critical and timely information/access which not only saves and extends lives, but ultimately improves the day-to-day lives of those living with the disease. Named the “National Voice for Brain Cancer Patients” the Chris Elliott Fund is happy to consult with patients, caregivers, and doctors regarding brain cancer issues and concerns at any time. CEF's co-founder and President Dellann Elliott is available at 425.785.8489 or Dellann(at)ChrisElliottFund(dot)org. Find out more about this organization at

Learn about the LIVESTRONG and Genentech REV forum and how REV will be a catalyst for action.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rachel Tougher
Follow us on
Visit website